Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Corpus Striatum | 5 | 2020 | 60 | 1.340 |
Why?
|
| Reward | 4 | 2018 | 64 | 1.060 |
Why?
|
| Dopamine | 5 | 2020 | 232 | 1.050 |
Why?
|
| Interpersonal Relations | 2 | 2019 | 57 | 1.040 |
Why?
|
| Decision Making | 4 | 2020 | 194 | 0.680 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2019 | 1325 | 0.670 |
Why?
|
| Brain | 5 | 2019 | 948 | 0.650 |
Why?
|
| Social Behavior | 1 | 2019 | 65 | 0.640 |
Why?
|
| Brain Mapping | 4 | 2019 | 178 | 0.580 |
Why?
|
| Neuronal Plasticity | 2 | 2007 | 80 | 0.530 |
Why?
|
| Synapses | 2 | 2007 | 83 | 0.520 |
Why?
|
| Choice Behavior | 2 | 2016 | 86 | 0.520 |
Why?
|
| Signal Transduction | 3 | 2020 | 680 | 0.500 |
Why?
|
| Memory | 2 | 2007 | 190 | 0.490 |
Why?
|
| Parkinson Disease | 4 | 2018 | 87 | 0.450 |
Why?
|
| Intelligence | 1 | 2012 | 5 | 0.410 |
Why?
|
| Models, Neurological | 1 | 2012 | 117 | 0.380 |
Why?
|
| Long-Term Potentiation | 2 | 2007 | 15 | 0.340 |
Why?
|
| Serotonin | 2 | 2020 | 38 | 0.330 |
Why?
|
| Mental Disorders | 1 | 2010 | 123 | 0.330 |
Why?
|
| Reactive Oxygen Species | 2 | 2007 | 157 | 0.330 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2006 | 36 | 0.320 |
Why?
|
| Cognition | 1 | 2012 | 556 | 0.300 |
Why?
|
| Hippocampus | 2 | 2006 | 170 | 0.290 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2006 | 6 | 0.280 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 34 | 0.250 |
Why?
|
| Photic Stimulation | 4 | 2020 | 158 | 0.250 |
Why?
|
| Games, Experimental | 2 | 2015 | 4 | 0.220 |
Why?
|
| Humans | 13 | 2020 | 32082 | 0.210 |
Why?
|
| Neurons | 1 | 2005 | 407 | 0.200 |
Why?
|
| Animals | 5 | 2011 | 7510 | 0.170 |
Why?
|
| Visual Perception | 1 | 2020 | 116 | 0.170 |
Why?
|
| Conditioning, Operant | 2 | 2012 | 88 | 0.160 |
Why?
|
| Child Development | 1 | 2019 | 43 | 0.160 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 71 | 0.160 |
Why?
|
| Feedback, Psychological | 1 | 2018 | 6 | 0.150 |
Why?
|
| Male | 8 | 2020 | 19202 | 0.140 |
Why?
|
| Oxygen | 3 | 2016 | 142 | 0.140 |
Why?
|
| Mesencephalon | 1 | 2016 | 18 | 0.140 |
Why?
|
| Female | 7 | 2020 | 19999 | 0.140 |
Why?
|
| Attitude | 1 | 2014 | 40 | 0.120 |
Why?
|
| Politics | 1 | 2014 | 22 | 0.120 |
Why?
|
| Emotions | 1 | 2014 | 58 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 764 | 0.110 |
Why?
|
| Child | 1 | 2019 | 2439 | 0.100 |
Why?
|
| Intelligence Tests | 1 | 2012 | 9 | 0.100 |
Why?
|
| Blood Gas Analysis | 1 | 2012 | 17 | 0.100 |
Why?
|
| Personality | 1 | 2012 | 16 | 0.100 |
Why?
|
| Group Processes | 1 | 2012 | 15 | 0.100 |
Why?
|
| Behavior | 1 | 2012 | 30 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2012 | 53 | 0.100 |
Why?
|
| Deep Brain Stimulation | 1 | 2011 | 49 | 0.090 |
Why?
|
| Economics | 1 | 2010 | 6 | 0.090 |
Why?
|
| Neurosciences | 1 | 2010 | 11 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2012 | 547 | 0.090 |
Why?
|
| Mice | 2 | 2006 | 2474 | 0.090 |
Why?
|
| Imitative Behavior | 1 | 2008 | 2 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2008 | 8 | 0.080 |
Why?
|
| Gyrus Cinguli | 1 | 2008 | 22 | 0.080 |
Why?
|
| Mental Processes | 1 | 2008 | 17 | 0.080 |
Why?
|
| Self Concept | 1 | 2008 | 43 | 0.070 |
Why?
|
| Rats | 1 | 2011 | 1592 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 1 | 2007 | 35 | 0.070 |
Why?
|
| Maze Learning | 1 | 2006 | 13 | 0.070 |
Why?
|
| Learning | 1 | 2007 | 79 | 0.070 |
Why?
|
| Fear | 1 | 2006 | 48 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 101 | 0.070 |
Why?
|
| Phenotype | 1 | 2008 | 632 | 0.070 |
Why?
|
| Imidazolines | 1 | 2005 | 1 | 0.060 |
Why?
|
| Azoles | 1 | 2005 | 2 | 0.060 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2005 | 2 | 0.060 |
Why?
|
| Organoselenium Compounds | 1 | 2005 | 3 | 0.060 |
Why?
|
| Catalase | 1 | 2005 | 15 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2005 | 15 | 0.060 |
Why?
|
| N-Methylaspartate | 1 | 2005 | 12 | 0.060 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2005 | 18 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2005 | 25 | 0.060 |
Why?
|
| Lysine | 1 | 2005 | 23 | 0.060 |
Why?
|
| Acetylcysteine | 1 | 2005 | 11 | 0.060 |
Why?
|
| Free Radical Scavengers | 1 | 2005 | 14 | 0.060 |
Why?
|
| Metalloporphyrins | 1 | 2005 | 16 | 0.060 |
Why?
|
| Catecholamines | 1 | 2005 | 18 | 0.060 |
Why?
|
| Dopamine Agonists | 1 | 2005 | 28 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 42 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 77 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2005 | 75 | 0.060 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2005 | 32 | 0.060 |
Why?
|
| Mitochondria | 1 | 2007 | 185 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2005 | 135 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2006 | 443 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2005 | 228 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 164 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 288 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 392 | 0.060 |
Why?
|
| Middle Aged | 4 | 2020 | 11834 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2007 | 327 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 1020 | 0.050 |
Why?
|
| Adult | 4 | 2020 | 9375 | 0.050 |
Why?
|
| Avoidance Learning | 1 | 2018 | 19 | 0.040 |
Why?
|
| Aged | 2 | 2020 | 10308 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2014 | 155 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 3990 | 0.030 |
Why?
|
| Young Adult | 1 | 2016 | 2665 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 68 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 371 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 225 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2008 | 895 | 0.020 |
Why?
|
| Adolescent | 1 | 2008 | 3568 | 0.010 |
Why?
|